Compare AstraZeneca plc (AZN) vs Coinbase Global, Inc. (COIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Coinbase Global, Inc. — how do they compare? AstraZeneca plc trades at $158.61 (market cap $248.14B), while Coinbase Global, Inc. trades at $148.16 (market cap $39.20B). The key difference: AstraZeneca plc is far larger — about 6.3× Coinbase Global, Inc.'s market cap, and AstraZeneca plc pays a 2.01% dividend while Coinbase Global, Inc. pays none. Which is the better fit depends on your goals.
| AZN | COIN | |
|---|---|---|
Market Cap | $248.14B | $39.20B |
Sector | Health | Technology |
52-Week High | $209.48 | $387.27 |
52-Week Low | $147.06 | $141.09 |
Enterprise Value | $275.41B | $36.85B |
Dividend Yield | 2.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $157.39, down 2.79% amid bearish technical signals and merger speculation. The company demonstrates strong fundamentals with revenue growth to $58.74B in 2025 and a net income margin of 17.02%. Recent earnings have consistently beaten estimates, and analyst consensus is positive with 47.5% buy ratings. However, news of potential merger talks with Bristol Myers Squibb and a related legal investigation have introduced volatility.
The outlook is mixed; solid profitability and growth support long-term value, but near-term price pressure from technical indicators and merger uncertainty presents a cautious entry point. Key risks include deal execution challenges and integration complexities should a merger proceed.
COIN trades at $148.4, down 0.19% with a bearish technical signal. Recent earnings misses and a net loss in Q2 2026 highlight challenges despite revenue growth. The stock faces pressure from a sluggish crypto market, but maintains strong cash flow and a 55% analyst buy rating with a $207.20 price target.
Outlook remains mixed: strong fundamentals like positive EBITDA and cash flow support long-term potential, but near-term risks from earnings volatility and market sentiment weigh on performance. Investors should balance growth prospects against sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Coinbase Global, Inc.
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →
